Viewing Study NCT00876993


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2025-12-25 @ 11:27 PM
Study NCT ID: NCT00876993
Status: COMPLETED
Last Update Posted: 2023-07-03
First Post: 2009-04-06
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
Sponsor: Johns Hopkins All Children's Hospital
Organization: